Patent Assignment
Reel/Frame 070481/0182
Change of Name
Recorded: 2025-03-11
Pages: 4
Assignor
OCUPHIRE PHARMA, INC.
Executed: 2024-10-22
Assignee
OPUS GENETICS, INC.
37000 GRAND RIVER AVE., SUITE 120, FARMINGTON HILLS, MICHIGAN, 48335
Covered Property
(1)
Compositions Comprising an APX3330 Hemicalcium Salt Monohydrate and Therapeutic Uses Thereof
Application:
63/565,345 →
Related Assignments
(6)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Mar 11, 2025
From: ONICIU, DANIELA CARMEN
To: OPUS GENETICS, INC.
Reel/Frame 070475/0147 →
Assignment of Assignor's Interest
Mar 11, 2025
From: GREENE, MATTHEW BENJAMIN; CACACE, JANICE; HILKER, BRENT
To: CORERX, INC.
Reel/Frame 070475/0177 →
Assignment of Assignor's Interest
Mar 11, 2025
From: CORERX, INC.
To: OCUPHIRE PHARMA, INC.
Reel/Frame 070475/0219 →
Assignment of Assignor's Interest
Mar 11, 2025
From: ERNST, CHRISTOPHER KEITH
To: OPUS GENETICS, INC.
Reel/Frame 070475/0295 →
Security Interest
Apr 21, 2026
From: OPUS GENETICS, INC.
To: OPCM SA LLC, AS PURCHASER AGENT FOR THE SECURED PARTIES
Reel/Frame 075478/0138 →
Assignment of Assignor's Interest
Aug 5, 2026
From: OPUS GENETICS, INC.
To: APEXIAN PHARMACEUTICALS, INC.
Reel/Frame 075531/0886 →